These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24461301)

  • 61. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis.
    Abraldes JG; Tarantino I; Turnes J; Garcia-Pagan JC; Rodés J; Bosch J
    Hepatology; 2003 Apr; 37(4):902-8. PubMed ID: 12668985
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.
    Van den Branden C; Gabriels M; Vamecq J; Vanden Houte K; Verbeelen D
    Nephron; 1997; 77(3):319-24. PubMed ID: 9375827
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients.
    Sharma P; Kumar A; Jha S; Mishra SR; Sharma BC; Sarin SK
    Aliment Pharmacol Ther; 2010 Jul; 32(1):105-12. PubMed ID: 20345511
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis.
    Stanley AJ; Therapondos G; Helmy A; Hayes PC
    J Hepatol; 1999 Mar; 30(3):479-84. PubMed ID: 10190732
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of atorvastatin on portal hemodynamics and clinical outcomes in patients with cirrhosis with portal hypertension: a proof-of-concept study.
    Bishnu S; Ahammed SM; Sarkar A; Hembram J; Chatterjee S; Das K; Dhali GK; Chowdhury A; Das K
    Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):54-59. PubMed ID: 29099421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
    Burza MA; Marschall HU; Napoleone L; Molinaro A
    Pharmacol Res; 2017 May; 119():20-26. PubMed ID: 28099882
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. After proper optimization of carvedilol dose, do different child classes of liver disease differ in terms of dose tolerance and response on a chronic basis?
    Wani ZA; Baht RA; Bhadoria AS; Maiwall R; Majeed Y; Khan AA; Zargar SA; Shah MA; Khan KM
    Saudi J Gastroenterol; 2015; 21(5):278-83. PubMed ID: 26458853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Single and repeated doses of the vasodilator/beta-adrenergic antagonist, carvedilol, block cirazoline- and isoproterenol-mediated hemodynamic responses in the conscious rat.
    Smith EF; Slivjak MJ; Gagnon R
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):499-504. PubMed ID: 1360255
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The effect of propranolol on portal hypertension].
    Kovacević N; Tomić D; Perisić-Savić M; Grbić R
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():62-4. PubMed ID: 18193814
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nipradilol, a new beta-blocker with vasodilatory properties, in experimental portal hypertension: a comparative haemodynamic study with propranolol.
    Um S; Nishida O; Tokubayashi M; Kimura F; Kita T
    J Gastroenterol Hepatol; 1993; 8(5):414-9. PubMed ID: 8105997
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemodynamic effects of nipradilol, a new beta-adrenergic antagonist combined with a nitroxy base, in rats with intra- or extra-hepatic portal hypertension.
    Ohsuga M; Cailmail S; Lebrec D
    J Hepatol; 1993 Feb; 17(2):236-40. PubMed ID: 8095275
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK
    Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
    Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.
    Schepke M; Raab P; Hoppe A; Brensing K; Paar D; Potyka U; Sauerbruch T
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1451-8. PubMed ID: 10571601
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of adrenoceptor blocking drugs on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study.
    Nieminen T; Ylitalo R; Kööbi T; Ylitalo P; Kähönen M
    Arzneimittelforschung; 2005; 55(4):205-11. PubMed ID: 15901043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.
    Steib CJ; Gerbes AL
    Hepatol Int; 2017 Mar; 11(2):141-142. PubMed ID: 28233256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.